Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

282
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
282
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

96
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
96
Pharmacovigilance01:19

Pharmacovigilance

876
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
876
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

89
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
89
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

64
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
64
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

757
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
757

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

DispFormer: A dual attention transformer with denoising for biomedical irregular time series classification.

Journal of biomedical informatics·2026
Same author

A temporal deep learning algorithm for prediction of extubation failures in critical care patients.

Journal of clinical monitoring and computing·2026
Same author

DynaMamba: Multi-scale dynamic interacting Mamba network for irregular clinical time series classification.

Journal of biomedical informatics·2026
Same author

Contextual information contributes to biomedical named entity normalization.

Journal of biomedical informatics·2025
Same author

Self-Supervised Molecular Representation Learning With Topology and Geometry.

IEEE journal of biomedical and health informatics·2024
Same author

Revisiting Drug Recommendation From a Causal Perspective.

IEEE journal of biomedical and health informatics·2024

相关实验视频

Updated: Jul 15, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K

形状:用于药物推的样本自适应层次预测网络.

Sicen Liu, Xiaolong Wang, Jingcheng Du

    IEEE journal of biomedical and health informatics
    |September 28, 2023
    PubMed
    概括

    这项研究介绍了SHAPE,这是一个新的AI模型,用于在患有多种复杂疾病的患者中推药物. 通过更好地了解患者病史和访问数据,SHAPE提高了准确性.

    科学领域:

    • 医疗信息学 医疗信息学
    • 医疗保健中的人工智能
    • 临床决策支持 临床决策支持

    背景情况:

    • 对复杂多病症患者的药物推具有挑战性.
    • 现有的方法往往忽视了内访事件关系和可变的患者纵向数据结构.

    研究的目的:

    • 提出一个新的样本适应性等级医学预测网络 (SHAPE).
    • 为了解决编码内诊医疗事件和学习可变长度患者序列的局限性,以准确推药物.

    主要方法:

    • 开发了一个紧的内访问集编码器,用于访问级别的表示.
    • 设计了一个访问间的纵向编码器,以实现有效的患者级纵向表示.
    • 实施软课程学习方法来处理可变的访问长度.

    主要成果:

    • 与最先进的基线相比,SHAPE模型显示出更高的性能.
    • 在基准数据集上的实验结果验证了模型的有效性.

    结论:

    • 在复杂的多病症病例中,SHAPE提供了一种有效的药物推方法.
    • 该模型的自适应层次结构和学习策略提高了预测准确性,并处理了数据的变化.

    更多相关视频

    Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
    05:47

    Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

    Published on: June 13, 2025

    261
    Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
    04:09

    Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

    Published on: October 10, 2018

    8.3K

    相关实验视频

    Last Updated: Jul 15, 2025

    A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
    12:18

    A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

    Published on: January 11, 2020

    7.6K
    Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
    05:47

    Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

    Published on: June 13, 2025

    261
    Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
    04:09

    Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

    Published on: October 10, 2018

    8.3K